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Abstract 
Objectives: Implant supported single metal-ceramic crowns cemented either extraorally or 
intraorally, were comparatively evaluated by clinical, radiologic, biomarker and 
microbiological data. 
Materials & Methods: Twelve patients with one missing tooth at each side of the maxilla 
received 2 locking-taper implants; 4.5 mm width, 8 mm length. Selection of intraoral 
cementation (IOC) or extraoral cementation (EOC) using screwless titanium abutments was 
done randomly. Peri-implant crevicular fluid (PICF), gingival crevicular fluid (GCF) samples 
were collected from the implants and adjacent teeth in the same individuals before starting the 
prosthetic procedures (baseline) and 3, 6 months after implant loading. Radiographs were 
taken immediately after and 6 months after cementation and crestal bone loss was measured. 
Cytokine levels, amounts of bacteria were determined in PICF/GCF samples. Data were 
tested by appropriate statistical analyses. 
Results: All clinical parameters were similar in the crowns cemented extraorally or 
intraorally at all times (p<0.05). PICF data were similar to GCF data. Lower amounts of IL-
17E and OPG levels were observed in the intraorally cemented crowns.   
Conclusion: EOC and IOC implant supported metal-ceramic single crowns exhibited similar 
crestal bone loss after loading. However, at 3 months, differences in anti-inflammatory 
processes and stimulation might be suggested at IOC crowns.  
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Introduction 
Intraosseous dental implants are frequently preferred treatment choice for rehabilitation of 
partial or total edentulous patients to reduce the physical and cosmetic consequences of tooth 
loss. Implants restored with fixed dental prosthesis (FDPs) have high survival rate in spite of 
the fact that mechanical, aesthetical or biological complications may occur in clinical use. 
Biological complications can be categorized as surgery-related implant loss, bone loss and 
peri-implant soft tissue diseases.1 Bacteria play a major role in the etiology of peri-implant 
diseases, which can be restricted to the soft tissues in terms of mucositis or progress to the 
supporting bone and induce bone destruction; namely peri-implantitis.  
Implant supported FDPs can be fixed on implants either by screws or by cementation. 
Survival rates for single-unit screw retained and cemented prosthesis were shown to be 89.3% 
(95% CI: 64.9%-97.1%) and 96.5% (95% CI: 94.8%-97.7%), respectively without any 
statistical significant difference.2 Both techniques have their own advantages and 
disadvantages, cemented restorations have less technical complications (24.4% vs. 11.9%), 
whereas biological complications are more frequently associated with cemented crowns 
(2.8% vs. 0%).3,4 It is known that excess cement left in the peri-implant mucosa/sulcus 
promotes the formation of biofilm leading to inflammation in the peri-implant tissues and 
cause biological complications.5 A clinical study by Wilson6 reported a positive relation 
between residual cement and development of chronic peri-implant diseases. In order to 
eliminate the biological complications of cemented reconstructions, screw retained prostheses 
can be preferred in certain cases. However, an implant with locking taper connection does not 
have a retention screw and single crowns could be extra-orally cemented and therefore, may 
eliminate the negative consequences of both screw retained and cemented prosthesis while 
preserving the positive aspects of both techniques.     
Inflammation affecting the peri-implant tissues causes mucositis and peri-implantitis via 
similar inflammatory mechanisms acting in the pathogenesis of gingivitis and periodontitis. 
There are studies reporting similar content of the pathogenic bacteria in the biofilm around 
dental implants and natural teeth7,8,9 while differences in bacterial species in the same 
individuals was demonstrated recently suggesting distinct pathogenic mechanisms.10  It is also 
shown that presence of A. actinomycetemcomitans, Prevotella intermedia, Porphyromonas 
gingivalis, Treponema denticola, and F. nucleatum at the implant sulcus was affected by the 
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presence or absence of these microorganisms in the gingival crevice of adjacent teeth rather 
than other sites in the dentition. 9 
Interactions between the three members of the tumor necrosis factor (TNF) superfamily; 
receptor activator of NF-κB ligand (RANKL), RANK, and osteoprotegerin (OPG) are 
important in coordination of osteoclastogenesis and alveolar bone resorption.11 RANKL binds 
directly to RANK on the surface of preosteoclasts, osteoclasts and stimulates both the 
differentiation of osteoclast progenitors and activity of mature osteoclasts. OPG is the 
naturally occurring inhibitor of osteoclast differentiation. It is a soluble molecule that binds to 
RANKL with high affinity and blocks RANKL from interacting with RANK.12  
On the other hand, interleukin-17 (IL-17) synergizes with other cytokines, including IL-1β, 
TNF-α. IL-17A increases RANKL expression and concomitantly decreases OPG expression 
in osteoblastic cells in vitro and in vivo, thereby enhancing osteoclast formation and bone 
erosion.13 In contrast with the other IL-17 family cytokines IL-17E is an anti-inflammatory 
cytokine, which opposes the functions of IL-17A.14 The levels of inflammatory biomarkers 
are expected to change in periimplantitis15 and periodontits16 sites and therefore, their levels 
could be informative for the inflammatory status of periimplant and periodontal tissues.  
It was hypothesized that due to the reduced risk of excess cement, extraorally cemented 
implant-supported crowns exhibit less crestal bone loss and microbiological load, and smaller 
amounts of inflammatory biomarkers than intraorally cemented crowns. Therefore, the aim of 
this clinical study was to comparatively evaluate the implant supported metal-ceramic crowns 
cemented either intraorally or extraorally by clinical, biomarker, and microbiological 
parameters during the 6-months period after implant loading. Moreover, the biomarker and 
microbiological data were compared with those around the natural adjacent teeth in the same 
individuals in an attempt to compare the process around natural teeth and implants. 
Materials and Methods 
Study population and design 
This study was carried out at Ege University, School of Dentistry between May 2014 and 
June 2016. Detailed medical and dental histories were obtained from all volunteer participants 
and clinical, radiographical examinations were performed. The procedures related to the study 
was reviewed and approved by the Ethical Board of Ege University School of Medicine with 
the protocol number of 14-5/18. 
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Clinical evaluations including occlusion, interocclusal distances, parafunctions, endodontic 
and periodontal lesions, and soft tissues surrounding the edentulous space were made. 
Panoramic radiographs were evaluated for bone pathologies, vertical dimensions of the 
available bone, and distances to the anatomical structures. Nonsurgical periodontal therapy 
consisting motivation and instruction on oral hygiene, scaling and root-planing was provided 
as required. Patients were informed about all prosthetic rehabilitation alternatives with or 
without implant-supported restorations and all individuals signed the informed consent form 
before enrolment in the study.  
Inclusion criteria were; presence of bilateral single tooth gap in the maxillary posterior region 
with the extractions performed at least 6 months ago, presence of adjacent teeth on both sides, 
presence of sufficient bone height and width at the alveolar crest, at least 2-mm vestibular 
keratinized mucosa width and 3 mm mucosa thickness, and with no history of periodontitis. 
Furthermore, a full-mouth plaque score of < 20 % was a prerequisite for implant placement. 
Patients with known systemic diseases, conditions or those using medications with potential 
to impair surgery and wound healing dynamics and also smokers were excluded from the 
study. Moreover, patients with bone height < 8 mm, presenting ridge and soft tissue 
deficiencies that require augmentation procedures, and having endodontic or periodontal 
lesions neighboring the edentulous sites were also excluded.  
Twelve patients (7 males and 5 females, age range 35-45 years) fulfilling the inclusion criteria 
were scheduled for surgical procedures.  
Surgical procedures 
All the surgical procedures were carried out at the Department of Periodontology, School of 
Dentistry, Ege University. Following local anesthesia (2% lidocaine with 1:100 000 
epinephrine), the soft tissue thickness corresponding to mid-crestal incision line was 
measured by bone sounding at mesial, middle and distal aspects.  A mid-crestal incision was 
then placed and continued intrasulcularly to mid-facial and mid-palatal area of adjacent teeth. 
A full thickness flap was then elevated to visualize the alveolar crest and the vestibulo-palatal 
thickness was measured to validate the width of the crest. Following the initial osteotomy 
with a pilot drill at 800 rpm under saline irrigation, the consecutive drills were used at 50 rpm 
without irrigation in line with the manufacturers’ instructions.  
The depth of the osteotomy slightly exceeded the length of the implant and the width of the 
osteotomy was the same as the implant diameter. Implants with locking-taper that allows 
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extraoral cementation of single crowns were placed by the same periodontist (NN). All the 
implants (Bicon LLC, Boston, MA, USA) had the same diameter and length (4.5 x 8 mm). 
 After the implants were placed into the osteotomy by slight vertical tapping a healing cap of 
the same size (3 mm height, 5 mm diameter) was installed. Non-absorbable 5-0 silk sutures 
were placed (Medipac SA, Kilkis Greece). Surgeries on both sites were carried out in a single 
session. Antibiotics were not prescribed following the implant surgery. Patients cleaned the 
surgical area with a postoperative dental brush (GUM Delicate Post-surgical toothbrush, 
Sunstar Americas Inc, Chicago, IL, USA) and avoided flossing at the surgical area. The 
sutures were removed at the first week, and the patients were evaluated monthly thereafter. 
During the osseointegration period the patients strictly complied with oral hygiene measures.  
Prosthetic procedures 
Following the implant surgery a 3-month period was allowed for osseointegration and single 
PFM crowns were fabricated for each patient. The implant used in the current study has a 
locking taper connection, and the abutment of the system fits into the well of the implant 
without a retentive screw. This structure enables cementation of a crown prior to installation 
of the abutment into the implant.  At the first prosthetic stage, a closed-tray technique with 
transfer posts was used for taking the impressions. Impression (Virtual, Ivoclar Vivadent, 
Schoon, Lichtenstein) and bite registration material was polyvinyl siloxane (Memoreg 2, 
Heraeus Kulzer, Germany). The impression posts and implant analogs were installed and 
placed into the impression as described by the manufacturer. After the master cast is obtained 
in the laboratory, the titanium abutments of the same size were chosen and the shoulders of 
the abutments were prepared 1mm subgingivally at all sites so that the crown margins were 
located 1 mm below the gingival margin. When the metal-ceramic crowns were fabricated 
following standard procedures the cementation steps were initiated. The intra-oral 
cementation (IOC) and extra-oral cementation (EOC) groups were randomly assigned at the 
final prosthetic stage by a researcher blinded to the study by toss of a coin. The abutments in 
the IOC group were cleaned, sterilized, and placed into the implants, and after the shoulders 
of the abutment was confirmed to be 1mm subgingivally, slight vertical tapping was 
performed to assure the cold weld between the implant and the abutment. The crowns were 
then cemented over the abutments using zinc polycarboxylate cement (Poly-F Plus; Dentsply 
International, York, PA, USA). After the setting, maximum care was taken to remove excess 
cement around the abutments. The abutments in EOC group were also placed into the 
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implants to confirm the position of the shoulder and then removed back to perform EOC 
procedures. The crowns were cemented extra-orally using the same material and the excess 
cement was thoroughly cleaned before the final installation of the abutment into the implants 
as described for IOC group. After completion of the prosthetic stage, patients were recalled 
for clinical evaluation, at 3 and 6 months follow-up sessions. During this period, patients were 
motivated and instructed for optimum plaque control but flossing around the implants was 
avoided. 
Clinical and radiographic recordings 
Clinical evaluations were performed at baseline and also at 3, 6 months after placement of 
implants and construction of single unit porcelain fused to metal crowns (PFM). Soft tissue 
inflammation around the implants and natural teeth were evaluated by presence or absence of 
bleeding on probing (0=absent, 1=present). Soft tissue thickness at the implant sites was 
measured on the day of surgery by bone sounding using a straight periodontal probe and a 
rubber stop. The keratinized tissue width was measured as the distance between the 
gingival/mucosal margin and the mucogingival junction. All the measurements were rounded 
up to the nearest 0.5 mm.   
Standardized periapical radiographs were taken immediately (baseline) and 6 months after 
cementation using the long-cone paralleling technique (Kodak 2100 230 V; Carestream 
Health Inc Rochester, NY) and appropriate position holders (Rinn XCP, Dentsply Corporate, 
York, PA, USA) and parameters set at 0.125 sec exposure time, 60 kV, and 70 mA. Images 
were transferred to computer by a photostimulatable phosphor plate scanner (Digora Optime, 
Soredex, Milwaukee, WI, USA) and radiographs were used to measure the crestal bone loss at 
the mesial and distal surfaces of the implants. The radiographs were stored as digital images 
and on each image the implant length and implant diameter were used as the reference for 
measurements. Implant-abutment interface and first bone to implant contact was depicted on 
each image and the vertical distance between these two points were noted as the crestal bone 
level (CBL). The bone loss at 6 months was calculated subtracting the CBL at baseline from 
the CBL at 6-months. The follow-up radiographs were randomly numbered by a periodontist 
not involved in the study and all radiographic assessments were performed following the 
numeric order by the same investigator (BK) in a blinded manner. 
Collecting biofluid and microbiological samples  
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Peri-implant crevicular fluid (PICF), gingival crevicular fluid (GCF) samples and 
microbiological samples were obtained from two sites of each implant and adjacent tooth in 
the same individuals before starting the prosthetic procedures (baseline) and also 3, 6 months 
after cementation of crowns. If the implant was a premolar the neighboring premolar, and if 
the implant was a molar the adjacent molar tooth was chosen for sampling. All samples were 
collected by the same researcher (BK). First, the sampling sites were isolated by cotton rolls 
and healing abutment surfaces were air-dried gently. Paperstrips (Periopaper; ProFlow, Inc., 
Amityville, NY, USA) were inserted 1 mm into the crevice and left in place for 30 sec. Care 
was taken to avoid mechanical injury and those samples with visual blood contamination 
were discarded. The PICF/GCF volume absorbed on each paper strip was determined by a 
specific electronic impedance device (Periotron 8000, ProFlow, Inc., Amityville, NY, USA) 
and both strips from each implant or tooth were placed in one sterile precoded polypropylene 
tube and kept at -40°C until the laboratory analysis. The readings from the Periotron 8000 
were converted to actual volumes (µl) by reference to the standard curve.  
Microbiological samples were collected using paperpoints (ISO 45). ....... 
Elution of PICF/GCF 
The PICF/GCF samples were eluted from paperstrips into 500 µl PBS by vortexing the 
sample vigorously for 30 sec, the paperstrip was removed and microorganisms in the sample 
were pelleted by centrifugation at 14 000 g for 10 min and the supernatant was transferred to 
a clean tube.   
Measurement of RANKL, OPG, IL-1, IL-17A, IL-17E levels in PICF/GCF samples  
Commercial ELISA kits were purchased for the measurement of OPG (R&D Systems 
Abingdon, UK), sRANKL, IL-17A, IL-17E (Peprotech London, UK), IL-1 (Thermo Fisher 
Paisley, UK). The ELISA assays were carried out according to the manufacturers’ 
recommendations. The optical densities were read at 450 nm with a background subtraction at 
570 nm and the samples were compared with the standards. The minimum detection limits for 
the assays were as follows OPG: 7.56pg/ml; RANKL: 7.56 pg/ml; IL-17A, IL-17E: 0.79 
pg/ml; IL-1: 0.79 pg/ml. The PICF/GCF data were expressed as total amounts per sampling 
time (pg/30sec) and also as concentrations (pg/µl).  
Microbiological analyses 
Preparation and assessment of genomic DNA 
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The Epicentre Masterpure Gram positive DNA isolation kit (Cambio, Cambridge, UK) was 
used to prepare genomic DNA from the pelleted microbes present on paper points and from 
known quantities of laboratory strains of the target microorganisms. The amount of DNA and 
the purity was checked at 260 nm and 280 nm (260/280 nm ratio = 1.8-2.0 = good DNA 
purity) using a NANODROP 1000 spectrophotometer (Thermo Renfrew, UK). The DNA 
from laboratory strains was measured by fluorimetric analysis using the CYquant assay 
system (Invitrogen Paisley, UK) and the value plotted against the copy number bacteria use as 
standards for each bacterial assay.  
Real-time quantitative polymerase chain reaction (RT-QPCR) 
A RT-QPCR assay using TaqMan chemistry (ABI/Invitrogen Paisley, UK) was used for the 
detection and quantification of bacterial cell copy numbers. The primers and probes selected 
for the following bacteria were as published in the sources shown: Porphyromonas gingivalis, 
Aggregatibacter actinomycetemcomitans, Prevotella intermedia, Tannerella forsythia, 
Fusobacterium nucleatum17,18,19,20 Treponema denticola,21 Streptococcus salivarius,22 and 
were purchased from Invitrogen (Paisley, UK). 
Statagene MRX III thermal cycler (Agilent Edinburgh, UK), the TaqMAN assay PCR cycling 
parameters used in the study were 10 min at 95°C, and 40 cycles of 30 sec at 95°C and 1 min 
at 60°C. All primer sets were validated by running four serial 1/10 dilutions of the standard 
DNA and calculating the efficiency of the reaction (E) where E= (10 -1/slope)-1.  
All reaction efficiencies calculated were acceptable (between 91% and 104%). All primer sets 
failed to amplify the DNA purified from different microbial standards.  
Statistical analyses 
Microsoft Excel and commercially available statistical software (SPSS Inc. version 21 IBM, 
Chicago, USA and Graphpad Prism version 5, La Jolla, USA) were used to analyze the data. 
Statistical power calculation indicated that to exceed 80% statistical power where the effect 
size =1 a minimum of 23 individuals should be sampled for a non-parametric analysis using 
independent sample tests and for paired (dependent) sample tests the minimum number of 
participants N=12.  With effect size =1.5, 80% statistical power was achievable in 
independent sample tests with N=12.   
After assessing that the data distribution was skewed as determined by a Q-Q plot, the data 
were analyzed by nonparametric tests. The Friedman test with a post hoc Dunn’s test was 
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used to determine significance levels between baseline and the sample time points. 
Differences between the treatment sites were assessed by the Mann-Whitney U-test. 
Correlations between the clinical parameters and the microbial analysis, and between 
biomarker data were evaluated with Spearman rho rank correlation test. All tests were 
performed at α = 0.05 significance level.  
Results 
Clinical and radiographic findings  
All patients included in the present study completed the study protocol. The number of molars 
and premolars was 8 and 4, respectively. Clinical and radiographic findings are shown in 
Table 1. No excess cement was seen at any of the x-rays. According to the statistical analysis, 
no significant differences were found between control teeth (C), EOC and IOC groups in 
terms of crestal bone loss, soft tissue inflammation or PICF/GCF sample volumes (p<0.05). 
Biomarker findings 
Biomarker findings are shown in Table 2 and Table 3. There were no significant differences 
in RANKL, OPG, IL-17A, IL-17E, IL-1 levels or RANKL/OPG ratio between the study 
groups at baseline or at the 3-, 6-month evaluations (Table 2). RANKL, IL-1 levels and 
RANKL/OPG, IL-17A/IL-17E ratios were similar within each study group between baseline 
and follow-up evaluations (Table 2). The total amounts of OPG and IL-17E were significantly 
lower at the 3-month evaluation than the baseline values in the intraoral cementation group 
(p=0.03, p=0.013, respectively). IL-17A/IL-17E ratio was significantly higher in the intraoral 
cementation group than the extraoral cementation group (p=0.03) at the 3-month evaluation 
(Table 2).  At 6 months concentrations of sRANKL, OPG and IL-17A were lower in the EOC 
group than in the control group (p=0.013, p=0.024 and p=0.031, respectively) but no 
significant differences were seen between the IOC group and the EOC group or the IOC 
group and the control group (Table 3).   
 
Microbiological findings 
Microbiological findings are shown in Table 4 and Table 5. Levels of A. 
actinomycetemcomitans, P. intermedia, T. forsythia, T. denticola, S. salivarius as well as the 
total bacterial load were similar in the study groups at all times (Table 2). F. nucleatum level 
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(Table 4) and percentage (Table 5) were significantly lower in the samples of the intraorally 
cemented implants than those around the natural teeth at the third month (p=0.03). At 
baseline, P. gingivalis levels were significantly higher (p=0.02) in the control teeth than those 
around the extraorally cemented implants (Table 4).   
 
Discussion 
Peri-implantitis is usually diagnosed by clinical measures such as bleeding on probing, 
suppuration and radiographic findings of bone resorption.23 Local risk factors such as excess 
cement seem to play an important role in the etiology of peri-implant diseases.24,25 Various 
studies have focused on the relationship between excess cement and peri-implantitis.6,26,27,28 
There are published clinical protocols for the cementation procedure29 but it has proven 
difficult to completely eliminate excess cement risk at the cement retained implant crowns. 
Therefore, EOC technique in particularly single implant crowns with taper locking implant 
systems may be a good alternative to eliminate excess cement risk. The present study was 
undertaken in order to compare IOC and EOC techniques and their potential impact on 
clinical, biochemical, and microbiological parameters. The two different cementation 
techniques were used in the same patients to minimize individual differences that may act on 
the host response to cement remnants, cement material itself and resident bacteria. Moreover, 
only those patients with bilateral single tooth gaps were included in the study in order to limit 
possible patient-related confounding factors. 
Published studies mostly suggest that biomarker and microbiological data are similar around 
natural teeth and intraosseous dental implants as long as the clinical health state is similar.7,30 
Accordingly, the present study revealed similar findings in the PICF and GCF samples. This 
finding can be regarded as a further support for the similarity of the milieu/media of peri-
implant and periodontal environments.   
The prevalence of peri-implant diseases around implants with cemented restorations were 
reported to be 75 % and 64 % of those being positive for cement excess.22 Excess cement 
without inflammation of the peri-implant tissue was rarely detected with permanent cement 
and amounted 8.5-8.8 %.31,32 In a recent review investigating the role of excess cement as a 
possible risk indicator for peri-implant diseases, it was found that undetected excess cement 
occurred irrespective of the cement medium or type of abutment used, and the prevalence was 
higher with short soft tissue healing periods. In order to eliminate that risk the healing 
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abutments were placed at the day of implant placement and a 3-month soft tissue healing 
period was allowed in the current study. Moreover, in the same review it was suggested that 
an early detection of the disease and accompanied excess cement up to 5 month after 
restoration placement was more often related to the diagnosis of peri-implant mucositis as the 
early stage of the disease process than with peri-implantitis.33 Even though the follow-up 
period in the current study slightly exceeded the time limit suggested by Staubli et al.,33 the 
crestal bone change in IOC and EOC groups are more likely to be a consequence of 
physiologic bone remodeling rather than an outcome of the cementation technique. 
Screw-retained prostheses may be considered as alternatives for cement-retained ones to 
eliminate problems arising from the use of excess cement. However, screw-retained 
prostheses have major drawbacks such as screw loosening, esthetic problems, difficulty in 
fabrication and in providing a passive fit, etc. In order to provide an acceptable final result 
with screw retained prosthesis the implant requires an optimum 3D positioning, which is not 
always achievable. Since the cemented prostheses are generally the treatment of choice in the 
daily practice, we compared the IOC and EOC techniques.  
In a recent study, Canullo et al.34 compared EOC and IOC techniques 
with“traditional”chamfer abutment design or feather-edge abutment design. The authors 
suggested that EOC technique could minimize the presence of cement remnants, but they also 
observed that there were little cement remnants in the IOC group. They considered the 
possibility of cement-induced pathology to be very low. These findings are supported by the 
current findings since excess cement related peri-implant pathology was not detected in the 
present study. Apart from the cementation technique, the type of cement and accurate cement 
cleaning are the other determining factors for the presence or absence of excess cement and 
related pathology.  
A major limitation of the present study is that the study included a rather small population and 
the conditions of a conservative a priori power analysis were difficult to achieve. This was 
due to the difficulties in recruiting patients that fulfilled the inclusion criteria; particularly 
where the split-mouth design rather than a parallel arm study design was chosen. However, 
sufficiently large effect sizes were achieved for some of the chosen biomarkers: OPG, 
sRANKL, Il-17A and IL-17E and for the microbes F. nucleatum and P. gingivalis.  
Inflammation in the peri-implant tissues may be latent in the early stages and not readily 
detected by clinical measures. Therefore, PICF analysis might provide valuable information 
 13
for the early diagnosis of inflammatory changes and might even serve as a tool for 
determination of patient susceptibility.35 Although differences were observed with the control 
site measurements at 3 and 6 months, particularly for the EOC sites the present study revealed 
similar biomarker and microbiological data in the PICF samples obtained from the EOC and 
IOC sites. This finding can be explained by the efficacy of cement removal from 1 mm depth 
of crown margins in IOC techniques, thus, it should be noted that pushing the crown margin 
deeper than this threshold may change the results obtained in the current study. Moreover, the 
periodontal and peri-implant tissues were healthy at baseline leading to similarly low levels of 
inflammatory biomarkers in the biofluid samples. The patients were followed for 6 months 
after loading of implants. One has to concede that this period may be too short for detection of 
some of the changes in the inflammatory cytokine content of PICF/GCF sample. IL-1 and 
IL-17A, IL-17E are more related to soft tissue inflammation and their levels are known to 
increase during the early stages of inflammation around teeth or implants. A transient change 
in these markers could have been missed by the sampling protocol. Although a difference in 
the amount of the anti-inflammatory cytokine IL-17E was observed to be greater at the EOC 
sites than the IOC sites. The importance of this finding remains unclear although this cytokine 
is a key player in tissue healing.  
However, most of the cytokine levels were similar at the different study sites and this might 
be explained by appropriate oral care provided by the patients. On the other hand, RANKL 
and OPG levels and particularly the ratio of RANKL/OPG is regarded as a reliable biomarker 
for bone loss in periodontitis or peri-implantitis. A higher amount of OPG was seen at 3 
months at the EOC sites compared to the IOC sites. Whether this is an important finding 
needs further clarification, however, one is tempted to speculate that this might bode well for 
good osseointegration. The present findings revealed similar levels and proportions of several 
bacteria in the samples obtained from sites at EOC or IOC implants as well as their adjacent 
teeth with the following exceptions: F. nucleatum at 3 months and lower P. gingivalis levels 
at baseline than at the control tooth sites. Previous studies that compared screw-retained 
abutments with cement-retained abutments reported that cement-retained abutment implants 
offered better results relating to fluid and bacterial permeability when compared to screw-
retained abutment implants.36,37 Our microbiological data is in line with these previous studies 
and further emphasizes the need for complete removal of the fixation cement particularly after 
intraoral cementation. Presence of an inflammatory cell infiltrate at the implant-abutment 
junction has been described even around implants with very good hygiene and healthy peri-
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implant tissues.38 This appears to be accompanied by bacterial plaque accumulation that 
cannot be completely prevented. Accordingly, the present study indicated presence of various 
bacteria, even of several putative periodontal pathogens at the implant sites without appearing 
to cause clinically detectable inflammation.  
 Conclusion  
EOC and IOC implant-supported metal-ceramic crowns exhibited similar clinical 
performance during the 6-month follow-up period. Differences in microbiological and 
biomarker data were few between the two cementation techniques. At 3-month evaluation, a 
transient decrease in anti-inflammatory processes and an increase in osteoclast stimulation 
might be suggested at IOC sites and a higher carriage of F. nucleatum was observed at EOC 
sites. It may be suggested that EOC is a safe and reliable method for the single crowns on the 
implants with locking taper and the clinical outcome is similar to that obtained in IOC sites 
with 1mm subgingival margins. Further clinical studies comparatively evaluating the EOC 
and IOC techniques particularly for sites with subgingival margins >1mm are warranted.  
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Table 1. Clinical and radiographic parameters of the study sites 
Clinical Parameter Evaluation times Control Mean ± SD 
IOC  
Mean ± SD 
EOC  
Mean ± SD 
PICF/GCF Volume (µl) 
T0 1.38±0.53 1.06±0.6 1.21±0.66 
T3 1.55±0.37 1.51±0.63 1.41±0.48 
T6 1.51±0.3 1.57±0.49 1.93±0.09 
BOP (+/-) 
T0 0±0 0±0 0±0 
T6 0.06±0.10 0.19±0.40 0.03±0.09 
Crestal Bone Loss  
Mesial T0-T6 0.00-0.00 0.14±0.42 0.14±0.46 
Distal T0-T6 0.00-0.00 0.19±0.47 0.20±0.68 
STT 
Mesial T0 - 3.50±0.52  3.75±0.58 
Middle T0 - 3.17±0.33  3.21±0.45 
Distal T0 - 3.79±0.50 3.58±0.51 
KTW 
 T0 3.0±0.56 2.92±0.56 2.96±0.84 
 T6 2.92±0.42 2.75±0.66 2.88±0.57 
T0: Baseline, T3: 3rd month, T6: 6th month, IOC: Intraoral cementation group, EOC: Extraoral 
cementation sites, STT: Soft Tissue Thickness (mm), KTW: keratinized tissue width (mm). 
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 Table 2. Median (innerquartile range) total amounts of biomarkers in GCF/PICF at study sites 
 Biomarker Evaluation 
Time 
Control       
Median (q1-q3) 
IOC                  
Median (q1-q3) 
EOC                                
Median (q1-q3) 
RANKL (pg) 
T0 163 (147-206) 156 (111-220) 159 (104-246) 
T3 188 (87.6-222) 173 (131-208) 153 (103-205) 
T6 177 (140-203) 159 (104-184) 137 (112-181) 
OPG (pg) 
T0 114 (101-128) 149 (97.9-182) 118 (72.1-141) 
T3 108 (72.2-152) 79.5 (43.3-153)* 120 (84.7-147)† 
T6 112 (87.8-141) 88.7 (46.6-140) 98.8 (85.7-146) 
IL-17A (pg) 
T0 15.0 (12.0-16.7) 15.1 (11.3-43.4) 15.4 (13.6-17.7) 
T3 15.7 (13.2-21.0) 14.5 (11.5-16.3) 12.8 (9.79-16.0)* 
T6 13.7 (12.5-15.5) 14.2 (13.2-18.4) 12.8 (10.4-17.6) 
IL-17E (pg) 
T0 27.9 (16.7-46.6) 48.0 (31.1-69.2) 23.8 (17.1-37.9) 
T3 31.8 (19.6-44.7) 12.2 (8.44-40.2)* 36.8 (24.7-47.6)† 
T6 30.0 (20.2-44.4) 20.2 (15.8-31.4) 28.3 (22.0-38.53) 
IL-1β (pg) 
T0 7.96 (6.48-9.38) 6.81 (4.01-9.60) 6.18 (4.17-12.6) 
T3 7.09 (4.35-9.62) 8.55 (6.90-10.8) 7.44 (4.98-9.14) 
T6 7.7 (6.75-9.97) 7.24 (2.96-8.82) 7.00 (4.79-9.62) 
RANKL/OPG 
T0 1.33 (1.08-2.11) 1.00 (0.69-3.13) 1.72 (0.96-2.84) 
T3 1.59 (1.32-2.03) 2.01 (1.25-3.31) 1.15 (0.82-1.58) 
T6 1.93 (1.31-2.75) 1.38 (1.26-2.44) 1.47 (1.13-1.72) 
IL-17A/IL-17E 
T0 0.68 (0.52-0.87) 0.56 (0.23-1.00) 0.54 (0.37-1.06) 
T3 0.48 (0.41-1.22) 0.80 (0.48-1.63)   0.32 (0.23-0.68)*† 
T6 0.71 (0.43-1.08) 0.78 (0.58-1.2) 0.52 (0.27-0.87) 
T0: Baseline. T3: 3rd month. T6: 6th month. IOC: Intraoral cementation sites. EOC: Extraoral 
cementation sites. *Statistically different from the control sites. †Statistically different from the IOC 
sites. 
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Table 3. Median (innerquartile range) concentrations of biomarkers in GCF/PICF at study sites 
 Biomarker Evaluation 
Time 
Control              
Median (q1-q3) 
IOC                
Median (q1-q3) 
EOC                       
Median (q1-q3) 
RANKL (pg/µl) 
T0 113 (104-190) 124 (81.9-330) 193 (92.3-252) 
T3 102 (61.4-168) 105 (72.0-217) 106 (71.9-163) 
T6 108 (97.3-126) 98.1 (82.3-128) 71.9 (57.3-94.3)* 
OPG (pg/µl) 
T0 80.3 (53.5-171) 163 (124-208) 95.0 (60.9-147.6) 
T3 81.9 (47.8-117) 65.9 (22.8-135) 85.6 (51.5-100) 
T6 75.8(69.5-95.9) 74.9 (33.5-103) 53.7 (42.9-75.4)* 
IL-17A (pg/µl) 
T0 9.93 (6.76-34.0) 22.6 (8.63-59.3) 13.6 (8.49-19.1) 
T3 11.4 (7.53-14.7) 7.71 (6.32-25.7) 9.42 (7.60-11.5) 
T6 8.89 (8.28-13.3) 10.7 (7.13-12.9) 6.62 (5.68-8.80)* 
IL-17E (pg/µl) 
T0 19.9 (11.3-70.0) 54.7 (27.5-81.7) 22.5 (16.2-41.9) 
T3 24.1 (13.1-40.4) 11.3 (4.98-27.1) 25.8 (15.7-45.0) 
T6 17.0 (12.66-27.4) 14.5 (9.07-21.0) 15.1 (11.0-19.6) 
IL-1β (pg/µl) 
T0 4.97 (4.23-10.3) 5.47 (4.59-9.03) 5.16 (4.53-12.6) 
T3 4.87 (2.80-6.49) 5.23 (4.42-9.77) 5.20 (3.83-7.77) 
T6 4.78 (4.24-6.76) 4.65 (2.51-5.85) 3.74 (2.45-5.00) 
 
T0: Baseline. T3: 3rd month. T6: 6th month. IOC: Intraoral cementation sites. EOC: Extraoral 
cementation sites. *Statistically significantly different from the control site. 
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Table 4. Median (innerquartile range) 16S gene copy number of putative periopathogens at study 
sites. 
Putative 
pathogen 
Evaluation 
time 
Control                                            
Median (q1-q3) 
IOC                        
Median (q1-q3) 
EOC                           
Median (q1-q3) 
 T0 1814 (633-5409) 986 (483-1715) 992 (373-2610) 
A.a. T3 6952 (1657-21571) 1010 (491-8153) 2203 (541-9248) 
 T6 1623 (1016-3090) 618 (301-4299) 3840 (480-8847) 
 T0 117822 (86164-152086) 78933(22483-158432) 98417(30406-218439) 
F.nucleatum T3 189604 (81068-418548) 43026(18481-126448)* 111925(40730-349994)† 
 T6 338670(149893-1316507) 141810(66558-261812) 150072(68296-411439) 
 T0 460 (244-787) 186 (82.5-323) 111 (0.00-234)* 
P.gingivalis T3 431 (200-1405) 529 (151-1384) 198 (55.5-1303) 
 T6 150 (85-536) 455 (40-1049) 333 (115-1447) 
 T0 25.3 (9.38-46.6) 14.5 (0.00-46.0) 13.0 (0.00-52.8) 
P.intermedia T3 42.5 (22.4-71.3) 72.0 (0.00-216) 34.0 (0.00-148) 
 T6 44.0 (0.00-95.5) 39.5 (0.00-115) 35.0 (.000-177) 
 T0 29.8 (17.3-63.1) 36.5 (0.00-277) 21.5 (0.00-88.3) 
T.denticola T3 14.5 (0.00-125) 0.00 (0.00-97.3) 0.00 (0.00-294) 
 T6 46.0 (0.00-182) 207 (73.5-586) 40.5 (0.00-207) 
 T0 33.5 (15.8-55.4) 35.0 (0.00-447) 26.5 (0.00-87.5) 
T.forsythia T3 18.8 (0.00-91.6) 12.5 (0.00-92.0) 0.00 (0.00-347) 
 T6 56.0 (0.00-189) 191 (58.5-287) 53.0 (0.00-388) 
 T0 29663 (3617-66735) 5588 (2653-96748) 4985 (1388-40436) 
S.salivarius T3 4328 (1105-37359) 5457 (409-75945) 1032 (175-6061) 
 T6 27000 (4976-58335) 11044 (4909-39548) 5398 (482-7501) 
 T0 146125(119479-1171681) 129179(718035-530179) 148047(70600-322569) 
Total T3 279618(164692-487707) 134948(43288-317958) 124429(66175-357859) 
 T6 493917(227335-2037433) 296357(102390-413909) 203631(110961-421209) 
   T0: Baseline, T3: 3rd month, T6: 6th month, IOC: Intraoral cementation group, EOC: Extraoral cementation 
group.    *Statistically different from the control sites. †Statistically different from the IOC sites. 
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Table 5: Median (innerquartile range) percentage of putative periopathogens at study sites. 
Putative 
pathogen 
Evaluation 
Time 
Control        
Median (q1-q3) 
IOC             
Median (q1-q3) 
EOC         
Median (q1-q3) 
 T0 1.38 (0.68-9.07) 0.89 (0.10-2.75) 0.90 (0.12-3.06) 
A.a. (%) T3 4.07 (1.4-7.59) 2.01 (0.23-10.3) 1.12 (0.18-12.2) 
 T6 0.74 (0.17-2.39) 0.49 (0.14-3.14) 0.69 (0.39-5.55) 
 T0 70.5 (49.8-88.4) 87.5 (0.11-95.2) 79.4 (57.6-96.0) 
F.nucleatum (%) T3 80.5 (71.4-92.2) 51.1 (18.4-81.4)* 92.3 (81.5-98.8)† 
 T6 68.9 (60.1-85.3) 73.8 (54.8-94.1) 93.5 (79.6-96.8) 
 T0 0.26 (0.16-0.64) 0.09 (0.01-0.48) 0.10 (0.00-0.23)* 
P.gingivalis (%) T3 0.53 (0.11-0.73) 0.52 (0.08-2.04) 0.23 (0.02-0.67) 
 T6 0.19 (0.03-0.68) 0.21 (0.01-0.79) 0.13 (0.05-0.44) 
 T0 0.01 (0.00-0.02) 0.00 (0.00-0.04) 0.01 (0.00-0.05) 
P.intermedia (%) T3 0.05 (0.01-0.11) 0.05 (0.00-0.31) 0.02 (0.00-0.08) 
 T6 0.01 (0.00-0.03) 0.01 (0.00-0.09) 0.00 (0.00-0.03) 
 T0 0.03 (0.00-0.05) 0.00 (0.00-0.13) 0.00 (0.00-0.04) 
T.denticola (%) T3 0.00 (0.00-0.10) 0.00 (0.00-0.06) 0.00 (0.00-0.14) 
 T6 0.01 (0-0.17) 0.04 (0.02-0.51) 0.03 (0.00-0.12) 
 T0 0.02 (0-0.04) 0.00 (0.00-0.07) 0.00 (0.00-0.06) 
T.forsythia (%) T3 0.00 (0.00-0.16) 0.00 (0.00-0.07) 0.00 (0.00-0.16) 
 T6 0.01(0.00-0.14) 0.07 (0.01-0.20) 0.03 (0.00-0.21) 
 T0 17.09 (5.5-28.3) 8.93 (3.40-93.1) 11.0 (1.15-29.2) 
S.salivarius (%) T3 6.37 (1.62-17.0) 7.08 (0.54-64.0) 0.52 (0.21-1.62) 
 T6 29.5 (5.62-38.6) 5.82 (1.41-37.2) 1.43 (0.23-13.4) 
T0: Baseline, T3: 3rd month, T6: 6th month, IOC: Intraoral cementation sites, EOC:Extraoral 
cementation sites. *Statistically different from the control sites. †Statistically different from the IOC 
sites. 
 
 
